Has Nima Kokabi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,048,528 in general payments to Nima Kokabi, MD across 635 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nima Kokabi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nima Kokabi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nima Kokabi, MD

Vascular & Interventional Radiology · Atlanta, GANPI 1932495298

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Sirtex Medical Inc accounts for 64.5% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $464,063, more than ten times the $632 reported in 2019. Among vascular & interventional radiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,048,528in general payments, 2019–2025

Across 635 payments — averaging $1651.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sirtex Medical Inc$676K
Okami Medical, Inc.$207K
Trisalus Life Sciences, Inc.$74K
Boston Scientific$56K
Siemens Medical Solutions USA, Inc.$9K
Balt USA, LLC$9K
plus $18K from 7 others

$151,624in research payments, 2019–2025

Across 43 payments — averaging $3526.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sirtex Medical Inc$67K
Boston Scientific$45K
Okami Medical, Inc.$40K

What the payments were for

Consulting fees$331,43932%
Speaking & faculty fees$617,01059%
Travel & lodging$81,9848%
Food & beverage$18,0952%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sirtex Medical Inc	440	$676,262
Okami Medical, Inc.	80	$206,709
Trisalus Life Sciences, Inc.	6	$73,600
Boston Scientific	48	$56,228
Siemens Medical Solutions USA, Inc.	7	$9,008
Balt USA, LLC	12	$8,507
Terumo Medical Corporation	23	$7,378
Galvanize Therapeutics, Inc	2	$7,200
BD	1	$1,785
AstraZeneca	3	$1,278
Medtronic(2 entities)	10	$363
Johnson & Johnson	2	$151
Bard Peripheral Vascular, Inc.	1	$56

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SIR-Spheres Microspheres$672,302
LOBO$205,215
TRINAV INFUSION SYSTEM$73,600
TheraSphere Y90 Glass Microspheres 10 GBq$19,364
Prestige Coil System$8,396
ALIYA SYSTEM$7,200
Azur CX Detachable$5,557
TheraSphere Administration Set$5,119
EMBOLD Fibered$1,837
Optima Coil System$1,322
Ballast 088 Long Sheath$1,322
HYBRID Guidewire$1,322
Eclipse 2L$1,322
IMFINZI$1,074
Navicross$700
TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$600
OBSIDIO$569
GlideWire$350
LAVA LES (Liquid Embolic System)$154
GLIDESHEATH SLENDER$146

How this compares

$1,048,528 in reported general payments places this provider in the 95th percentile of 120 vascular & interventional radiology providers in Georgia.

See all vascular & interventional radiology providers in Georgia →

Medicare billing

Part B allowed, 2024

$69,909

Medicare patients

155

Services billed

662

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Levofloxacin	11	$14

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Atlanta

Jason LevyAtlanta$822K
Aravind ArepallyAtlanta$249K
Kei YamadaAtlanta$154K
Kirema Garcia-ReyesAtlanta$115K
John PrologoAtlanta$97K
Jonathan MartinAtlanta$82K
Steven CitronAtlanta$66K
Kevin CarsonAtlanta$37K
Jun Man KimAtlanta$21K
Sendhil SubramanianAtlanta$17K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →